Lipika Chablani: AAPS 2011 Profile and Podcast - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Lipika Chablani: AAPS 2011 Profile and Podcast


Lipika Chablani



Lipika Chablani

Add this Podcast feed to your media player



Lipika Chablani (PhD Candidate)
Department of Pharmaceutical Sciences
College of Pharmacy and Health Sciences
Mercer University, Atlanta, Georgia 30341, USA.
Thesis Title: Formulation of Novel Particulate Breast Cancer Vaccines using Spray Drying and In Vivo Evaluation of Vaccine Efficacy
M.S. in Industrial Pharmacy, College of Pharmacy and Health Sciences, Buies Creek, Campbell University, North Carolina 27506.
B.Pharm., K.M.Kundnani College of Pharmacy, Mumbai University, Mumbai, India 400018.

View Full Research Presentation

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here